M&A Deal Summary

Azurity Pharmaceuticals Acquires Sebela Pharmaceuticals - Bowel Prep Franchise

On November 17, 2025, Azurity Pharmaceuticals acquired life science company Sebela Pharmaceuticals - Bowel Prep Franchise from Sebela Pharmaceuticals

Acquisition Highlights
  • This is Azurity Pharmaceuticals’ 5th transaction in the Life Science sector.
  • This is Azurity Pharmaceuticals’ 4th transaction in the United States.
  • This is Azurity Pharmaceuticals’ 2nd transaction in Georgia.

M&A Deal Summary

Date 2025-11-17
Target Sebela Pharmaceuticals - Bowel Prep Franchise
Sector Life Science
Buyer(s) Azurity Pharmaceuticals
Sellers(s) Sebela Pharmaceuticals
Deal Type Divestiture

Target

Sebela Pharmaceuticals - Bowel Prep Franchise

Roswell, Georgia, United States
Sebela Pharmaceuticals' Bowel Prep Franchise includes prescription therapies for colonoscopy preparation and is based in Roswell, Georgia.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Azurity Pharmaceuticals

Woburn, Massachusetts, United States

Category Company
Founded 1998
Sector Life Science
DESCRIPTION

Azurity Pharmaceuticals is a privately held, specialty pharmaceutical company focusing on the development and commercialization of value-added proprietary drug products and technologies in the prescription compounding sector of the pharmaceutical industry. Azurity Pharmaceuticals was founded in 1998 and is based in Woburn, Massachusetts.


DEAL STATS #
Overall 5 of 5
Sector: Life Science M&A 5 of 5
Type: Divestiture M&A Deals 1 of 1
State: Georgia M&A 2 of 2
Country: United States M&A 4 of 4
Year: 2025 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2025-03-14 Covis Pharma

Luxembourg, Luxembourg

Covis Pharma is a global specialty pharmaceutical company that markets therapeutic solutions for patients with life-threatening conditions and chronic illnesses. Covis is focused on marketing and distributing an array of branded products used to treat chronic and life-threatening medical issues and improve patient outcomes in various therapeutic areas including respiratory, cardiovascular, gastroenterology, and central nervous system diseases. Covis Pharma was founded in 2011 and is based in Luxembourg, Luxembourg.

Buy -

Seller(S) 1

SELLER

Sebela Pharmaceuticals

Roswell, Georgia, United States

Category Company
Founded 2013
Sector Life Science
DESCRIPTION

Sebela Phartmaceuticals is committed to improving patients lives by developing, marketing and selling differentiated branded prescription pharmaceuticals that bring meaningful value to patients affected by gastrointestinal, dermatological and women’s health diseases. Sebela Pharmaceuticals was founded in 2013 and is based in Roswell, Georgia.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
State: Georgia M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2025 M&A 1 of 1